Related Experiment Videos
Quantitative angiogenesis in a syngeneic tumor spheroid model
I P Torres Filho1, B Hartley-Asp, P Borgström
1La Jolla Institute for Experimental Medicine, California 92037, USA.
This study introduces a new method to watch blood vessel growth in tumors using awake mice. By implanting a clear window into the skin, researchers can track how tumors develop their own blood supply over two weeks. This approach allows for precise, repeated measurements of tumor size and vessel patterns without needing to sacrifice the animals. The findings show rapid vessel formation and steady tumor growth, providing a useful tool for testing new cancer treatments.
Area of Science:
- Quantitative angiogenesis research within oncology
- Microvascular imaging in experimental pathology
Background:
Current methods for observing tumor blood vessel formation often require invasive procedures that limit long-term monitoring. That uncertainty drove the need for a noninvasive approach to track vessel development in real-time. Prior research has shown that traditional models often fail to capture the dynamic nature of microvascular changes over extended periods. No prior work had resolved how to maintain clear, repeated visualization of these processes in awake subjects. This gap motivated the development of a specialized chamber system for longitudinal studies. Researchers previously struggled to balance high-resolution imaging with the physiological needs of the host animal. Existing techniques frequently relied on terminal endpoints, which prevented the collection of continuous data from the same specimen. This study addresses these limitations by providing a platform for sustained, in vivo observation of vascular growth.
Purpose Of The Study:
The aim of this work was to develop a system for noninvasive, in vivo, and in situ study of tumor angiogenesis in awake mice. Researchers sought to overcome the limitations of traditional models that often require invasive or terminal procedures. This study addresses the need for a platform that allows for repeated, high-resolution observations of vascular growth. The authors intended to create a reliable method for tracking tumor development over an extended period. By using a transparent chamber, they aimed to visualize the interaction between tumor cells and host vessels. The motivation was to provide a tool capable of quantifying complex morphometric parameters in real-time. This project also aimed to demonstrate the applicability of the model for therapeutic and pharmacokinetic testing. The researchers focused on establishing a consistent protocol that works across different mouse strains.
Main Methods:
Review approach involves the implantation of a transparent titanium chamber into the dorsal skin of mice. The researchers prepare spheroids from Lewis lung carcinoma cells labeled with methylrhodamine. They remove a small section of skin to place these spheroids over the upper tissue layer. Video microscopy records the selected fields using both trans- and epi-illumination techniques. The team uses separate fluorescence filters to distinguish between the plasma and the tumor cells. This strategy allows for the continuous tracking of microvessel growth for up to fourteen days. The investigators calculate tumor area and various morphometric vessel parameters from the captured image data. This design ensures that all observations occur in awake animals without the need for terminal procedures.
Main Results:
Key findings from the literature indicate that vascular density follows a predictable expansion pattern over the two-week observation window. At day six, the vascular density and tumor area reached 81 and 19 percent of their maximum values. The recorded vascular densities were 106, 147, 183, and 173 cm-1 at days three, six, ten, and fourteen. Tumor volume demonstrated exponential growth characterized by a doubling time of two days. The initial tissue response involved venular and capillary dilation followed by the appearance of vascular buds. These sprouts eventually organized into functional networks within the tumor foci. The researchers observed similar growth dynamics when testing the model in nude mice. These results confirm that the system provides a reliable quantitative assessment of tumor progression in vivo.
Conclusions:
Synthesis and implications suggest this model provides a robust framework for longitudinal monitoring of vascular development. The authors propose that the dual-labeling technique enables precise tracking of tumor-vessel interactions over two weeks. This approach allows for the repeated quantification of morphometric parameters during active growth phases. Researchers indicate that the system is suitable for evaluating the efficacy of various anti-tumor agents. The findings demonstrate that vascular networks expand rapidly, reaching significant density levels within the first week. The authors state that the model supports mechanistic investigations into how tumors recruit their blood supply. This platform offers a reliable way to assess pharmacokinetic profiles of therapeutic compounds in a living system. The study confirms that these observations remain consistent across different mouse strains, highlighting the versatility of the method.
Frequently Asked Questions
The researchers propose that the mechanism involves initial venular and capillary dilation, followed by the emergence of buds and sprouts. This sequence leads to the formation of complex vascular networks within and around the tumor spheroid over a fourteen-day period.
The authors utilize a transparent titanium chamber implanted into the dorsal skin of mice. This device allows for the continuous, noninvasive observation of tumor spheroids using video microscopy and specific fluorescence filter sets for imaging.
The researchers state that the titanium chamber is necessary to maintain a stable, clear window for high-resolution imaging. This setup prevents tissue interference, allowing for the precise measurement of vessel density and tumor area in awake subjects.
The authors employ dual-labeling with methylrhodamine for tumor spheroids and FITC for plasma. This data type allows for the clear differentiation between tumor tissue and the surrounding host vasculature during the imaging process.
The researchers measure vascular density, which reached 106, 147, 183, and 173 cm-1 at days 3, 6, 10, and 14, respectively. Additionally, they track tumor area, noting that it reached 19% of its maximum value by day 6.
The authors propose that this model is applicable for testing angiostatic and cytotoxic anti-tumor agents. They suggest that the ability to perform repeated observations makes it a valuable tool for pharmacokinetic studies in vivo.